(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-WZZLD89');
window.addEventListener('pushdatalayer', function(event) {
const section = event.detail?.siteSection;
const subsection = event.detail?.siteSubsection;
const pageUrl = event.detail?.pageUrl;
const pageTitle = event.detail?.pageTitle;
const promptSelection = event.detail?.promptSelection;
const formId = event.detail?.formId;
const dataLayerEvent = {
event: event.detail.eventName,
eventCallback: function () {
document.dispatchEvent(new CustomEvent('postdatalayerpush', {
bubbles: true,
composed: true,
detail: event.detail,
}));
},
};
if (section) {
dataLayerEvent['site_section'] = section;
}
if (subsection) {
dataLayerEvent['site_subsection'] = subsection;
}
if (pageUrl) {
dataLayerEvent['pageUrl'] = pageUrl;
}
if (pageTitle) {
dataLayerEvent['pageTitle'] = pageTitle;
}
if(promptSelection){
dataLayerEvent['promptSelection'] = promptSelection;
}
if(formId){
dataLayerEvent['form_ID'] = formId;
}
window.dataLayer = window.dataLayer || [];
window.dataLayer.push(dataLayerEvent);
});
document.addEventListener('checkcookie', () => {
var hasCookie = document.cookie.split(';')
.some((cookie) => cookie.trim().startsWith('CookieConsent='));
document.dispatchEvent(new CustomEvent('hascookie', { detail: hasCookie }));
});
general deadlines and check back for specific dates.With the increasing number of new therapies being developed for use in MS, there is a need for physicians trained in conducting clinical trials. To this end, the Society established the Sylvia Lawry Physician Fellowship Program, named in honor of its founder. Clinical trials to test the safety and efficacy of therapies for multiple sclerosis are highly complex and require special expertise and knowledge to monitor this highly variable disease. This program provides the individual with an MD or equivalent medical degree with up to 3 years of formal training, under the tutelage of an established investigator, in key elements associated with conducting clinical trials in MS. Residents who have or will have received training in neurology or physiatry in the United States, and who are in the PGY3 or PGY4 stage or beyond, are eligible to apply. " c-nmssatomrichtext_nmssatomrichtext-host="">This funding opportunity is closed for 2025, and applications will open in Spring 2026. View our general deadlines and check back for specific dates. With the increasing number of new therapies being developed for use in MS, there is a need for physicians trained in conducting clinical trials. To this end, the Society established the Sylvia Lawry Physician Fellowship Program, named in honor of its founder. Clinical trials to test the safety and efficacy of therapies for multiple sclerosis are highly complex and require special expertise and knowledge to monitor this highly variable disease. This program provides the individual with an MD or equivalent medical degree with up to 3 years of formal training, under the tutelage of an established investigator, in key elements associated with conducting clinical trials in MS. Residents who have or will have received training in neurology or physiatry in the United States, and who are in the PGY3 or PGY4 stage or beyond, are eligible to apply. general deadlines and check back for specific dates.With the increasing number of new therapies being developed for use in MS, there is a need for physicians trained in conducting clinical trials. To this end, the Society established the Sylvia Lawry Physician Fellowship Program, named in honor of its founder. Clinical trials to test the safety and efficacy of therapies for multiple sclerosis are highly complex and require special expertise and knowledge to monitor this highly variable disease. This program provides the individual with an MD or equivalent medical degree with up to 3 years of formal training, under the tutelage of an established investigator, in key elements associated with conducting clinical trials in MS. Residents who have or will have received training in neurology or physiatry in the United States, and who are in the PGY3 or PGY4 stage or beyond, are eligible to apply. " c-nmssatomrichtext_nmssatomrichtext-host="">This funding opportunity is closed for 2025, and applications will open in Spring 2026. View our general deadlines and check back for specific dates. With the increasing number of new therapies being developed for use in MS, there is a need for physicians trained in conducting clinical trials. To this end, the Society established the Sylvia Lawry Physician Fellowship Program, named in honor of its founder. Clinical trials to test the safety and efficacy of therapies for multiple sclerosis are highly complex and require special expertise and knowledge to monitor this highly variable disease. This program provides the individual with an MD or equivalent medical degree with up to 3 years of formal training, under the tutelage of an established investigator, in key elements associated with conducting clinical trials in MS. Residents who have or will have received training in neurology or physiatry in the United States, and who are in the PGY3 or PGY4 stage or beyond, are eligible to apply.
Sylvia Lawry Physician Fellowships